Clinical Trial

Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 31, 2025 (before its estimated February 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to obtain implant survivorship and clinical outcome data for the commercially available Zimmer® Continuum™ Ceramic-on-Ceramic Bearing System when used in primary hip arthroplasty. This will be done by analysis of standard scoring systems, radiographs and adverse event records. Data will be used to monitor pain, mobility and survivorship, and to confirm the safety and efficacy of the Continuum Ceramic-on-Ceramic Bearing System.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-11-10; most recent amendment 2025-01-30.
Trial Details
NCT Number NCT03343171
Lead Sponsor Zimmer Biomet
Conditions Osteoarthritis, Avascular Necrosis, Inflammatory Arthritis, Post-traumatic Arthritis
Enrollment 203 participants
Start Date 2010-09-15
Primary Completion 2025-02 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-01-31